SERPINF1 and breast cancer: The novel findings here point out the potential roles that PEDF plays in BC metabolism and identified novel metabolic markers activated or downregulated by PEDF in TNBC, and showed us the metabolic perturbation of BC cells in two different conditions (normo- and hyperglycaemic), which can possibly assist with developing novel targets for treating patients with triple-negative BC.